Patent · US Active

Aerosol formulation for inhalation comprising an anticholinergic

US7611694B2 · kind B2 · utility

19Cited by
9References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 15, 2006
Grant dateNov 3, 2009
Priority date
Expiry dateJun 15, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/5375
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a propellant-free, aqueous aerosol formulation for anticholinergics of formula 1wherein X− denotes an anion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.